The Sientra Inc. (SIEN) Rating Increased to Hold at Zacks Investment Research

The Sientra Inc. (SIEN) Rating Increased to Hold at Zacks Investment Research

Sientra Inc. (NASDAQ:SIEN) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday.

According to Zacks, “Sientra, Inc. is a medical aesthetics company. The Company offers plastic surgery implantable devices for cosmetic and reconstructive surgery, including Breast Implants, Tissue Expanders, Body Contouring, Implants and Specialty Products. Sentra’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. It also offers a range of other aesthetic and specialty products. Sientra, Inc. is headquartered in Santa Barbara, California. “

Separately, William Blair reaffirmed a “market perform” rating on shares of Sientra in a research note on Wednesday, August 10th.

Shares of Sientra (NASDAQ:SIEN) opened at 8.62 on Wednesday. Sientra has a 1-year low of $2.78 and a 1-year high of $10.45. The firm’s market cap is $156.32 million. The company’s 50-day moving average price is $8.50 and its 200 day moving average price is $7.43.

Sientra (NASDAQ:SIEN) last issued its quarterly earnings results on Tuesday, August 9th. The company reported ($0.56) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.51) by $0.05. Sientra had a negative return on equity of 36.16% and a negative net margin of 297.09%. The firm had revenue of $6.20 million for the quarter, compared to the consensus estimate of $4.80 million. On average, analysts predict that Sientra will post ($2.31) EPS for the current year.

Several large investors have recently added to or reduced their stakes in SIEN. First New York Securities LLC NY raised its stake in Sientra by 411.4% in the second quarter. First New York Securities LLC NY now owns 15,343 shares of the company’s stock worth $101,000 after buying an additional 12,343 shares during the period. Paloma Partners Management Co bought a new stake in Sientra during the second quarter worth $198,000. Geode Capital Management LLC raised its stake in Sientra by 67.5% in the first quarter. Geode Capital Management LLC now owns 71,919 shares of the company’s stock worth $491,000 after buying an additional 28,980 shares during the period. State Street Corp raised its stake in Sientra by 23.9% in the first quarter. State Street Corp now owns 82,717 shares of the company’s stock worth $563,000 after buying an additional 15,954 shares during the period. Finally, Ameriprise Financial Inc. bought a new stake in Sientra during the second quarter worth $3,310,000. 68.85% of the stock is owned by institutional investors.

Sientra Company Profile

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Related posts

Leave a Comment